DHEA-treatment after infections displayed an increased survival rate, reduced bacterial contamination in the peritoneal fluid, decreased pro-inflammatory (e.g., TNF-α, IL-6) and enhanced anti-inflammatory cytokine release (e.g., IL-4, IL-10). The gene discussed is IL10; the disease is infection.